Nyxoah Stock (NASDAQ:NYXH)
Previous Close
$0.87
52W Range
$0.80 - $5.92
50D Avg
$1.35
200D Avg
$2.50
Market Cap
$89.63M
Avg Vol (3M)
$307.82K
Beta
1.00
Div Yield
-
NYXH Company Profile
Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.